INS and metabolic syndrome: Amyloidosis represents the most direct and causal complication of FMF, arising from chronic SAA-driven inflammatory deposition, whereas metabolic comorbidities, including T1DM, NAFLD, and MetS, may result from sustained cytokine imbalance, insulin resistance, and inflammasome-mediated tissue inflammation.